Dexmedetomidine versus Fentanyl in Children Undergoing Central Venous Catheter Placement at the Pediatric Intensive Care Unit: A Randomized Double-Blind Clinical Trial
Publish place: International Journal of Pediatrics، Vol: 10، Issue: 5
Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 117
This Paper With 12 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_INJPM-10-5_013
تاریخ نمایه سازی: 11 تیر 1401
Abstract:
Background: The amount of sedation required for children in the pediatric intensive care unit (PICU) is a usually challenging issue. Fentanyl is a commonly used sedative in PICU, but respiratory depression limits its use. Dexmedetomidine (DEX) is an effective sedative and anesthetic agent with negligible respiratory depression and hemodynamic stability.This study was aimed to assess the effects of using DEX as a sedative in comparison to fentanyl. Methods: We conducted a randomized double-blind clinical trial on children aging ۱ month to ۱۸ years who were required central venous catheter at PICU. The patients were randomized into the DEX and fentanyl (loading dose ۱ mcg/kg and ۱ mcg/kg/h for continuous infusion) groups. The primary outcome was defined as the time to achieve Ramsay Sedation Scale (RSS) ≥۳, along with the safety outcome. Results: A total of ۵۵ patients were recruited for the analysis between July ۷ and December ۳۰, ۲۰۲۰. The two groups were comparable at baseline. There was no statistical difference in the number of patients (۶۳% in DEX and ۵۰% in fentanyl group p=۰.۳۹) and the time of reaching RSS≥۳ (۱۰ min for DEX and ۱۵ min for fentanyl group p=۰.۰۹۸). Furthermore, the catheterization time between the two groups was not different when the agents were administered individually or with propofol (۱۵ min for DEX and ۱۷.۵ min for fentanyl, p=۰.۲۲۵, and ۲۲.۵ for DEX and ۳۰ min for fentanyl group, p=۰.۰۷۵ respectively); neither was the safety profile significantly different in the two groups. Conclusions: This study found that DEX as a primary sedative is non-inferior to fentanyl, and it could facilitate sedation alone or in combination with propofol.
Keywords:
Authors
Elaheh Karimpour-razkenari
Department of Clinical Pharmacy, Faculty of pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
Mohammad Reza Navaeifar
Pediatric Infectious Diseases Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Mohammadreza Rafati
Pharmaceutical Sciences Research Center, Department of Clinical Pharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
Monireh Ghazaeian
Pharmaceutical Sciences Research Center, Department of Clinical Pharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :